{"name":"RespireRx","slug":"respirerx","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":86916,"revenueGrowth":0,"grossMargin":0,"rdSpend":429532,"netIncome":-2102720,"cash":22781,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2015"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CX717 200 mg","genericName":"CX717 200 mg","slug":"cx717-200-mg","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"CX717 200 mg","genericName":"CX717 200 mg","slug":"cx717-200-mg","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOcG1hNDl3M3NJRDNCSm5udTRCN3owOVk4QkNwSGV0UUh6OVNDVXlVeWxuWG1rUkNlc0xWUzZIbDZnNmc4Um9XUTRiZWxJdVFRcURwb3dOQ21xRzN6cHFEb20xSlltLWR5TVBYTXF2aUNfRmQwaXRrQ1hyN0VSczFiNmRIYXNWM1FKRHA5QU5pcVJpOUU?oc=5","date":"2025-11-18","type":"pipeline","source":"Yahoo Finance","summary":"RespireRx Pharmaceuticals Inc. Announces SEC Order Making Findings and Revoking Registration of Securities and Future Plans with respect to its Common Stock - Yahoo Finance","headline":"RespireRx Pharmaceuticals Inc. Announces SEC Order Making Findings and Revoking Registration of Securities and Future Pl","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9yamhSR3AxeXpfNlFXZk9SMFJ4dnczT0JxREpiQ0lLODhoSmhJYkFSang4ZGJuS0pFR09reDVwX1M3UElFWHA2SGRlaUgxM0pjdlhMWi1nNnZWT3BOZVN3ckFxUlp5WGQ5YkJ1ZmFaWTREQUluOEJkRUh3VGE?oc=5","date":"2025-06-18","type":"pipeline","source":"pharmaphorum","summary":"Welsh biotech Draig emerges with $140m in financing - pharmaphorum","headline":"Welsh biotech Draig emerges with $140m in financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5YQ3pYeTV2cFJhQzlIbW16Yzl5Ujd5MWNmMS1ldHUzXzZsOXoxbGJNYUkzVmczdEttcXBUNmkyaGhCbE90TXpONXJtdzM3bDE0ZDZB?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"VINC Stock Price, News & Analysis | Vincerx Pharma - Stock Titan","headline":"VINC Stock Price, News & Analysis | Vincerx Pharma","sentiment":"neutral"},{"date":"2025-02-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-09-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-08-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-07-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-05-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-04-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-02-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-01-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2023-12-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2023-11-17","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxOb2s1NnV2TjhTcG5ON3hfN3lpQ0hYNDlRN0o2XzVqLXQxZUlzeU53RGdRa3VPckl2cGhSRFlERmdZSTltSHZBc0ltRllvUmp4ZGdZVDBMN05hNkdwYVRZZEdOYkFkX1gyMlNLOU5DRWxidjZ2TVdFNC1ZV0lOci0wNFhVRHJsTjBHcWFMcWl5LW9RMDZEZ0lENjZSYVFpOEUxYTBhbUEzTFp2Ni1LUVhjdllZcTVicnVlSjV3cEpzTXBZVXRnVFZhdUdiX0NtT1JxSFN5ZHBMMGp1RzlBd1gyYjVmUWJqV2l0TnJPb1RJMTdzVFRPUXFEc3JZNWlKNWtsVXlPdmRmZS1nWlExQ0FEN2lpNlVod0tGU2VlSTVILU1VNGhTUWdXVEVVdWN4MkxTLVV2eDNJYWUyZ0lwbkViWg?oc=5","date":"2023-10-12","type":"pipeline","source":"GlobeNewswire","summary":"RespireRx Pharmaceuticals Inc.’s Subsidiary ResolutionRx - GlobeNewswire","headline":"RespireRx Pharmaceuticals Inc.’s Subsidiary ResolutionRx","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPMENDMzZZamo1emVPNTdzbTRhNEI2M25QR0FmemdlOGpyM0tRMEFrRXBNVmZpRlFMTVRtcnRkbDdOMDFiV1FISE1jUVBPTDZ1ZHlPMmd1V3phX09Nc0h6aGVWcy1jNVU0WWRGQ0dfZmJhODAxc2lMN2lYYnNGZFRIWjQzalNmX0tlMDBRR2UwMlVDT3E3TEM2cVcxc2hRdjdqR051RVN3X2NKTG5OelF0ZnlJZE04SnVFMGZ3TTZoMjB6Ty12eHJwUDFyRkdVbUxXYkw0WEZIcTc3dnJ2VVE?oc=5","date":"2023-10-12","type":"pipeline","source":"proactiveinvestors.com","summary":"RespireRx Pharmaceuticals subsidiary inks MSA for dronabinol manufacturing - proactiveinvestors.com","headline":"RespireRx Pharmaceuticals subsidiary inks MSA for dronabinol manufacturing","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":86916,"revenuePeriod":"2015-12-31","revenueHistory":[{"value":86916,"period":"2015-12-31"},{"value":86916,"period":"2015-12-31"},{"value":61667,"period":"2014-12-31"},{"value":61667,"period":"2014-12-31"},{"value":48309,"period":"2012-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":429532,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-2102720,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":22781,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}